77 related articles for article (PubMed ID: 14520843)
1. [Efficacy and safety of the TAIS coronary stent implantation: nine month multicenter study].
Samko AN; Belenkov IuN; Batyraliev TA; Pershukov IV; Niiazova-Karben ZA; Sercelik A; Calenici O; Karaus A; Guler N; Eryonucu B
Ter Arkh; 2003; 75(8):12-7. PubMed ID: 14520843
[TBL] [Abstract][Full Text] [Related]
2. [Safety and current indications during "real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multicenter German Cypher Registry].
Zahn R; Hamm CW; Zeymer U; Schneider S; Nienaber CA; Richardt G; Kelm M; Levenson B; Bonzel T; Tebbe U; Schöbel WA; Sabin G; Senges J;
Herz; 2004 Mar; 29(2):181-6. PubMed ID: 15057439
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
[TBL] [Abstract][Full Text] [Related]
4. The new Polish stent Chopin. Assessment of safety and efficacy in the treatment of de-novo coronary lesions using percutaneous angioplasty.
Buszman P; Zurakowski A; Kinasz L; Gorycki B; Król M; Lewicki A; Flak Z; Milewski K; Zurek P
Kardiol Pol; 2005 May; 62(5):451-9; discussion 460-1. PubMed ID: 15928722
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
[TBL] [Abstract][Full Text] [Related]
6. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions.
Lefèvre T; Ormiston J; Guagliumi G; Schultheiss HP; Quilliet L; Reimers B; Brunel P; Wijns W; Buettner HJ; Hartmann F; Veldhof S; Miquel K; Su X; van der Giessen WJ
J Am Coll Cardiol; 2005 Aug; 46(4):592-8. PubMed ID: 16098421
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of paclitaxel-coated stents for treatment of native coronary lesions. First results of both the clinical and angiographic 18 month follow-up of TAXUS I.
Büllesfeld L; Gerckens U; Müller R; Grube E
Z Kardiol; 2003 Oct; 92(10):825-32. PubMed ID: 14579046
[TBL] [Abstract][Full Text] [Related]
8. [Two-year results after implantation of a metallic stent EPHESOS in patients with coronary heart disease].
Belenkov IuN; Samko AN; Batyraliev TA; Pershukov IV; Niiazova-Karben ZA; Besnili F; Levitskiĭ IV; Zhamgyrchiev ShT; Vural A; Kalenich O
Ter Arkh; 2005; 77(9):49-52. PubMed ID: 16281490
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
10. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
11. Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Urban P; Gershlick AH; Guagliumi G; Guyon P; Lotan C; Schofer J; Seth A; Sousa JE; Wijns W; Berge C; Deme M; Stoll HP;
Circulation; 2006 Mar; 113(11):1434-41. PubMed ID: 16534015
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stents in bifurcation lesions: to stent one branch or both?
Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R
Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532
[TBL] [Abstract][Full Text] [Related]
13. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
[TBL] [Abstract][Full Text] [Related]
14. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
[TBL] [Abstract][Full Text] [Related]
15. Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.
Buszman P; Trznadel S; Zurakowski A; Milewski K; Kinasz L; Król M; Kondys M
Kardiol Pol; 2007 Sep; 65(9):1041-6; discussion 1047-8. PubMed ID: 17975751
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
[TBL] [Abstract][Full Text] [Related]
17. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice.
Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME;
Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586
[TBL] [Abstract][Full Text] [Related]
19. Early and late clinical and angiographic outcomes following terumo coronary stent implantation.
Mak KH; Chan CN; Neoh KH; Damras T; Koh TH; Tan HC; Lim TT; Lau KW; Lim YT; Lim YL
J Invasive Cardiol; 2002 May; 14(5):239-42. PubMed ID: 11983943
[TBL] [Abstract][Full Text] [Related]
20. [Immediate and long-term results of implantation of the coronary stent "BioDiamond"].
Batyraliev TA; Samko AN; Pershukov IV; Niazova-Karben ZA; Levitskiĭ IV; Ozgul S; Serchelik A; Pia Iu; Besnili F; Dinler G; Aialp MR
Ter Arkh; 2002; 74(2):57-60. PubMed ID: 11899829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
